To understand the public’s preferences and willingness to pay for digital therapeutics (DTx) products for chronic disease management.
Based on a discrete choice experiment, an online questionnaire survey was administered via Wenjuanxing in February to March 2025, targeting the adult working population with independent spending capacity across the country. The preference outcomes were analyzed using a mixed logit model.
Higher product accuracy (β=1.006), greater ease of use (β=0.349), superior product efficacy (β=0.569), higher product risk (β=-2.104),significant long-term health benefits (β=0.670), and inclusion in the medical insurance reimbursement list (β=1.458)demonstrated substantial influence on respondents’ preferences (P<0.001). Specifically, compared with low-risk products,respondents’ willingness to pay for high-risk products decreased by 7 891 yuan, and coverage by the medical insurance reimbursement list increased willingness to pay by 5 466 yuan compared with no coverage.
It is necessary to improve the regulatory system for DTx, establish a multi-payment pattern with medical insurance payment as the core and a climate of paying for health value, enhance the usability of products, and ultimately promote the improvement of chronic disease management levels and the promotion of DTx.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |